Latest News :
Indiana CE requirements have changed. More...
 
 

 Home | About Us | FAQ | Privacy Statement | Site Map | Contact Us

 
     

  Also visit   
  

 
Home > CE for Doctors > Course Description  
 
TITLE Effect of Preservatives in Chronic Ocular Therapy
ABSTRACT: Patients with glaucoma and/or dry eye disease often require frequent dosing of topical medications to control their oculardisease. Detergents (such as benzalkonium chloride) and oxidants such as stabilized oxychloro complex) are commonly used as preservatives in multidose ophthalmic medications. A literature review was performed to investigate the clinical implications of preservatives in ophthalmic medications that are used for chronic diseases such as glaucoma and/or dry eye disease. Animal histopathologic studies and a recent patient study found that ophthalmic medications with benzalkonium chloride, unlike infiltration of the conjunctiva. Ocular damage seemed to be correlated with the level of preservative. A recent rabbit study comparing benzalkonium chloride-preserved medication with stabilized oxychloro-preserved medication, found significantly less corneal damage in the group treated with the latter agent. The type and amount of ophthalmic preservative that patients eyes are exposed to should be taken into account when treating patients with chronic ocular conditions such as glaucoma and/or dry eye disease.  Author(s): Robert J. Noecker, MD; Lisa A. Herrygers, MD
 
Company: Mediconcepts, Inc
Release Date: Unknown
CE Credits: 1
Price: $20.00
CE Format: PDF

 

 

  


Problem with a course or test?  Click HERE to request help from the CE provider. 

RATE THE COURSE
Help make EyeCEonline.com more useful! After you complete a course, please take a moment to rate your experience with the online course.


Rate this course: Poor
Fair
Average
Good
Excellent
Course name:
Email address (optional):
 Receive CE updates & news

    

 
 
 

 Home | About Us | FAQ | Privacy Statement | Site Map | Contact Us

 

Copyright 2006-2009  eyeCEonline.com - All Rights Reserved. Best viewed in 1024x768 resolution.
Any unauthorized reproduction or distribution of the contents of this website is prohibited.